Affluent Medical SA (EPA:AFME)

Market Cap	59.22M
Revenue (ttm)	5.27M
Net Income (ttm)	-14.74M
Shares Out	39.35M
EPS (ttm)	-0.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,753
Average Volume	4,638
Open	1.500
Previous Close	1.500
Day's Range	1.470 - 1.515
52-Week Range	1.160 - 1.965
Beta	0.70
RSI	45.26
Earnings Date	Dec 23, 2025

About Affluent Medical

Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. The company offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. Affluent Medical SA was founded in 2011 and is headquartered in Aix-en-Provence, France...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 78
• Stock Exchange: Euronext Paris
• Ticker Symbol: AFME

Financial Performance

In 2024, Affluent Medical's revenue was 5.35 million, an increase of 337.09% compared to the previous year's 1.22 million. Losses were -14.74 million, -5.84% less than in 2023.